Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

BACKGROUND: To optimize vaccine implementation visits for young children, it could be efficient to administer the first RTS,S/AS01 malaria vaccine dose during the Expanded Programme on Immunization (EPI) visit at 6 months of age together with Vitamin A supplementation and the third RTS,S/AS01 dose o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Vaccine
Главные авторы: Asante, Kwaku Poku, Ansong, Daniel, Kaali, Seyram, Adjei, Samuel, Lievens, Marc, Badu, Lydia Nana, Darko, Prince Agyapong, Buabeng, Patrick Boakye Yiadom, Boahen, Owusu, Rettig, Theresa Maria, Agutu, Clara, Harrison, Samuel Benard Ekow, Ntiamoah, Yaw, Anim, Japhet Adomako, Adeniji, Elisha, Dornudo, Albert Agordo, Gvozdenovic, Emilia, Dosoo, David, Sambian, David, Owusu-Boateng, Harry, Wilson, Elvis Ato, Prempeh, Frank, Vandoolaeghe, Pascale, Schuerman, Lode, Owusu-Agyei, Seth, Agbenyega, Tsiri, Ofori-Anyinam, Opokua
Формат: Artigo
Язык:Inglês
Опубликовано: 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611265/
https://ncbi.nlm.nih.gov/pubmed/32192811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.03.014
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы